history of glp 1 drugs Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Science's 2023 Breakthrough: GLP-1R Agonists

vivax isolates were evaluated ( Supplementary Material Table 2 )

The sheep model of IUGR is a powerful animal model to study not only the fundamental physiology of IUGR but also to test potential treatment options to restore growth trajectories

While 12 weeks of bright light exposure did not produce measurable improvements in sleep quality, glucose metabolism, or inflammatory markers, it significantly altered clock gene expression in peripheral blood mononuclear cells (PBMCs, specifically decreasing REV-ERB levels and increasing the REV-ERB/BMAL1 ratio)

Lim JW, Na W, Kim HO, Yeom M, Kang A, Park G, et al

The original online version of this article was revised: The authors name Moyawiah A